Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|May 4, 2012
Genetic, immunological and clinical risk factors for biliary strictures following liver transplantationSperanta Iacob, Vito R Cicinnati, Alexander Dechêne, et al.Gastrointestinal Endoscopy|March 18, 2017
Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation: a prospective, randomized, multicenter trialAndrea Oliver Tal, Fabian Finkelmeier, Natalie Filmann, et al.The Oncologist|June 8, 2022
Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable CholangiocarcinomaJörg Trojan, Albrecht Hoffmeister, Bruno Neu, et al.Liver Cancer|December 5, 2019
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationClemens Schotten, Lars P Bechmann, Paul Manka, et al.Hepatology (Baltimore, Md.)|August 5, 2010
Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activationAlexander Dechêne, Jan-Peter Sowa, Robert K Gieseler, et al.Journal of Clinical Medicine|August 6, 2020
Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective StudyJost Langhorst, Lale Umutlu, Benedikt Michael Schaarschmidt, et al.Zeitschrift Fur Gastroenterologie|November 25, 2024
[Staffing situation and basics requirement calculations in the inpatient and outpatient sector in Germany - a representative survey by the Working Group of Senior Gastroenterology Hospital Physicians (ALGK)]Thomas Frieling, Dieter Schilling, Birgit Terjung, et al.Clinical Colorectal Cancer|March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal CancerMarcel Wiesweg, Henning Reis, Tobias Köster, et al.Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitisSvenja Sydor, Paul Manka, Lea van Buren, et al.Pageof 6